Key facts
- This page summarizes ORIX CORP's Form 4 filing for ORMAT TECHNOLOGIES, INC. (ORA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Dec 2024, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Additional SEC filing notes
Section 16 status
ORIX CORP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
On December 13, 2024, ORIX Corporation ("ORIX") completed the sale of 3,700,000 of their shares of common stock, par value $0.001 per share ("Shares") of the Issuer pursuant to that certain Underwriting Agreement by and among ORIX, the Issuer and Goldman Sachs & Co. LLC (the "Underwriter"), dated December 11, 2024. The Underwriter has not yet exercised its option to purchase up to an additional 555,000 Shares, which option is exercisable for a period of 30 days after December 11, 2024 ("Over-Allotment Option").
Footnote F2
The sales price of $75.38 represents the $76.20 public offering price per Share, less the underwriting discount of $0.82 per Share.
Footnote F3
In addition to the reported transaction, 555,000 Shares that continue to be held by the Reporting Person are subject to the Over-Allotment Option.